CAS RN: 914453-95-5

Atosiban Acetate

Product Availability

Choose a grade to view its available package options.

6 package records4 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260204 100mg In stock Shanghai Inquiry
Batchno.20260531 10mg In stock Shanghai Inquiry
Batchno.20251104 1g Out of stock Inquiry
Batchno.20260411 250mg Out of stock Inquiry
Batchno.20250507 50mg In stock Shanghai Inquiry
Batchno.20250502 5mg In stock Shanghai Inquiry
  • Product code: starshine_CAS914453-95-5
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

914453-95-5 / acetic acid;(2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide

Standard CAS: 914453-95-5 Multi CAS: Yes

Basic Information

CAS
914453-95-5
Multi CAS
Yes
Molecular Formula
C45H71N11O14S2
Molecular Weight
1054.200000
Exact Mass
1053.462338
InChI
InChI=1S/C43H67N11O12S2.C2H4O2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2;1-2(3)4/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63);1H3,(H,3,4)/t23-,24+,27-,28+,29-,30-,31-,35-,36-;/m0./s1
InChIKey
SVDWBHHCPXTODI-QIWYXCRTSA-N

Computed Properties

Structural Parameters

Heavy atom count
72
Aromatic heavy atom count
6
Fraction Csp3
0.62
Rotatable bonds
18
H-bond acceptors
16
H-bond donors
12
Molar refractivity
265.92
TPSA
402.97

LogP / Solubility

WLOGP
-2.95
MLOGP
-2.5
XLogP3
-2.95
Consensus LogP
-2.8
Log S (ESOL)
-3.39
Class (ESOL)
Poorly soluble
Log S (Ali)
-6.07
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-6.22
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-11.25

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Get In Touch

Contact Us